CLINICAL TRIALS PROFILE FOR PENLAC
✉ Email this page to a colleague
All Clinical Trials for PENLAC
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01419847 ↗ | Topical Penlac Nail Lacquer for Onychomycosis in Children | Completed | Rady Children's Hospital, San Diego | Phase 4 | 2002-03-01 | Five months of therapy is sufficient to treat onychomycosis in children. Topical therapy of onychomycosis in children with Penlac nail lacquer has comparable efficacy and a superior cost and safety profile compared to systemic therapy. |
| NCT02644551 ↗ | The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis | Unknown status | 9305-9954 Quebec Inc | Phase 2 | 2016-11-01 | This will be an interventional safety and efficacy study of CELENT07 when used as a topical treatment of onychomycosis in the toenails (tinea unguium) of adults 18 years and older. This is randomized, double-blind, parallel design, placebo and active controlled study in patients with mild to moderate toenail distal lateral subungual onychomycosis (DLSO) (n=120). Subjects will be randomized (1:1:1) to receive CELENXT07, placebo of CELENXT07 or PENLAC®, daily for 52 weeks. Efficacy assessments will include complete cure, mycologic cure and clinical efficacy and safety and tolerability. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PENLAC
Condition Name
Clinical Trial Locations for PENLAC
Trials by Country
Clinical Trial Progress for PENLAC
Clinical Trial Phase
Clinical Trial Sponsors for PENLAC
Sponsor Name
